Objectives: To investigate the inter-and intra-individual variation in the excretion of pyridinium crosslinks of collagen in ®rst morning void urine samples in healthy young adults. Design: An observational study in which urinary pyridinium crosslinks of collagen were measured in fasting ®rst void urine samples over ®ve consecutive days. Setting: The study was conducted in the Department of Nutrition, University College, Cork, Ireland. Subjects: A total of 17 healthy young adults (11 females and 6 males) aged 22±26 y were recruited from University College, Cork. The subjects were without any history of bone or articular disease, and with no intake of medicine that could affect bone or cartilage metabolism. Results: There were large intra-individual variations in the excretion of both pyridinoline (Pyr) and deoxypyridinoline (Dpyr) in ®rst morning void urine samples and the ratios of intra-to inter-individual variation were high. In comparison, inter-individual variation in excretion of crosslinks was relatively low. No signi®cant dayto-day variation was observed either in Pyr or Dpyr excretion when either ®ve, four or three consecutive days or four or three non-consecutive days of urine sampling were used. However, there were signi®cant differences between any two consecutive or non-consecutive days in both Pyr and Dpyr excretion.
Introduction
The urinary excretion of pyridinium crosslinks of collagen (pyridinoline (Pyr) and deoxypyridinoline (Dpyr)) show particular promise as speci®c and sensitive biochemical indices of bone resorption (Eyre, 1992) . Seibel et al, (1992) reviewed the clinical application of these biochemical markers to a variety of metabolic bone diseases including, postmenopausal osteoporosis, rheumatoid arthritis, Paget's disease of bone, primary hyperparathyroidism, and metastatic bone disease, breast cancer and other tumours associated with hypercalcemia. An increased excretion of these crosslinks has been demonstrated in all of the above disease states (Seibel et al, 1992) . Thus, the measurement of pyridinium crosslinks in urine is now well established for screening and monitoring of clinical disorders of bone metabolism.
There is increasing interest in the application of urinary crosslinks of collagen for the investigation of the in¯uence of diet and lifestyle on bone metabolism (Blumsohn et al, 1994; New et al, 1996; Fujimura et al, 1997) . One of the limitations of using such biochemical indices is the interand intra-individual variation in the urinary excretion of these crosslinks which has been reported to be relatively large (Colwell et al, 1993; McLaren et al, 1993) . This is not a problem in studies of metabolic bone disease where crosslink excretion is elevated by 2±10 fold (McLaren et al, 1993) . However, such variation poses potential dif®culties for the investigation of more subtle changes in bone metabolism for example those resulting from the in¯uence of diet or physical activity.
The purpose of this study was to investigate the interand intra-individual variation in the excretion of pyridinium crosslinks of collagen in ®rst morning void urine samples in healthy young adults.
Materials and methods
Seventeen healthy subjects (11 females and 6 males) aged between 22±26 y were recruited from among a group of postgraduates at University College, Cork. The subjects were healthy without any history of bone or articular disease, and with no intake of medicine that could affect bone or cartilage metabolism. Subjects were supplied with suitable collection containers for urine samples and asked to collect fasting ®rst void morning urine samples between 7±9 am each day for ®ve consecutive days. The volunteers were allowed to eat and drink as usual the day and evening before the collection. Aliquots of urine were stored at 720 C on the morning of collection until required for analysis of Pyr and Dpyr.
Urinary pyridinium crosslinks were determined in urine by an HPLC method as described by Colwell et al, (1993) . Urinary creatinine concentration was determined on the fresh daily urine specimens for each subject by a colorimetric procedure using a diagnostic kit (Cat. No. 124, 192 Boehringer Mannheim GmbH, Germany). The urinary crosslink concentrations were expressed as nmol Pyr or Dpyrammol creatinine. Signi®cant differences in interindividual (person-to-person) and intra-individual (day-today) variation in urinary Pyr and Dpyr excretion over the consecutive ®ve day period were determined using repeated measures analysis of variance (ANOVA). The sample size necessary to estimate urinary crosslink excretion, using three days of urine collection per person, was calculated from the ratio of intra-to inter-individual variation for ®ve day urine collection as described by Van Staveren et al, (1982) .
Results
The mean urinary Pyr and Dpyr excretion for the group was 47.7 AE 9.9 and 14.2 AE 3.5 nmolammol creatinine, respectively, and with no signi®cant difference between the level of Pyr and Dpyr excretion in females (50.8 AE 10.9 and 15.4 AE 3.7 nmolammol creatinine, respectively) and males (42.1 AE 4.0 and 12.3 AE 2.0 nmolammol creatinine, respectively). Given the similarity in urinary crosslink excretion between males and females the inter-and intra-individual variations were examined for the whole group. Inter-individual variation was signi®cant (P 0.03) for urinary excretion of both Pyr and Dpyr in the group but was much lower than the intra-individual variation as evident from the ratios of the intra-to inter-individual variation of 4.3 and 3.8, respectively.
The changes in urinary Pyr and Dpyr excretion over ®ve consecutive days for the 17 individual subjects are shown in Figure 1 . Some subjects had little day-to-day variation in excretion of Pyr and Dpyr, for example subjects 2, 3, 5, and 9, whereas others had relatively large variation, namely subjects 7, 11, and 13. Taking the group as a whole, excretion of Pyr or Dpyr varies by not more than $ 1.2 fold from day-to-day as opposed to 2±3 fold differences in crosslink excretion from day-to-day within individual subjects.
The mean coef®cient of variation for Pyr and Dpyr excretion of the group over ®ve consecutive days was 21 and 24%, respectively. There were signi®cant differences (P`0.05) in both Pyr and Dpyr excretion between urine samples taken on any two consecutive days. However, if any of the two or three possible combinations of days using three or four consecutive or non-consecutive sampling days were analysed, no signi®cant variation was observed in either Pyr or Dpyr excretion. Similarly, if ®ve consecutive days were used to assess day-to-day variation no signi®cant variation was observed either in Pyr or Dpyr excretion. As a consecutive three day urine collection was the least number of sampling days that was needed to eliminate signi®cant day-to-day variation, the expressions derived by Van Staveren et al, (1982) were used to calculate the ratio of sample sizes in equivalent three day and ®ve day designs yielding the same precision. It was calculated that if a consecutive three day collection design was employed as opposed to the more tedious and time consuming ®ve day collection then it would be necessary to use $ 1.3 fold the sample number to achieve the same precision in the mean crosslink excretion of the group.
Discussion
No signi®cant difference was observed in mean urinary excretion of Pyr or Dpyr, expressed on a creatinine basis, between males and females, in agreement with the ®ndings of Rauch et al, (1994) .
There were large intra-individual variations (day-to-day variations) in the excretion of both crosslinks in ®rst morning void urine samples and the ratios of intra-to inter-individual variation were high. In comparison, interindividual variation in excretion of crosslinks, which is attributable to underlying differences between subjects, was relatively low. Variability in urinary pyridinium crosslinks F Ginty et al
The mean coef®cient of variation for Pyr and Dpyr excretion in the present group was 21 and 24%, respectively, similar to values for healthy adults reported by Colwell et al, (1993) (26% for both Pyr and Dpyr) and McLaren et al, (1993) (16 and 24% for Pyr and Dpyr excretion, respectively) . This day-to-day variation in crosslink excretion may be due to a variety of factors which have been shown to affect crosslink excretion including resistance exercise (Fujimura et al, 1997) , various dietary factors, for example calcium (Blumsohn et al, 1994) , K, Mg, ®bre and vitamin C (New et al, 1996) and possibly, the stage of the menstrual cycle in females (Gorai et al, 1995) . The relatively large day-to-day variation in urinary excretion of crosslinks emphasises the need to use multiple samples to characterise the crosslink excretion of an individual.
In this present study, involving healthy subjects, no signi®cant day-to-day variation was observed either in Pyr or Dpyr excretion when ®ve consecutive days were used. Similarly, if any of the two or three possible combination of days using three or four consecutive or nonconsecutive days of urine sampling were used, no signi®-cant variation was observed in either Pyr or Dpyr excretion. However, there were signi®cant differences (P`0.05) between any two consecutive or non-consecutive days in both Pyr and Dpyr excretion. Thus, urine sampling for these pyridinium crosslinks necessitates at least a three day collection to ensure that day-to-day effects are not a signi®cant source of variation included in the data analysis. This requirement in studies on healthy subjects may not apply to studies on subjects with arthritic disease or metabolic bone disorders in whom large (2±10 fold) increases in excretion of both crosslinks are observed (McLaren et al, 1993) .
